Multiple Sclerosis in America 2026 Multiple sclerosis (MS) stands as one of the most common disabling neurological conditions affecting young and middle-aged adults across the United States. As a chronic,…
Crohn's Disease in America 2026 Crohn's disease remains one of the most pressing chronic health challenges facing Americans today. As a form of inflammatory bowel disease (IBD), it causes persistent…
Veteran Suicide Prevention in America 2026 The veteran suicide prevention in the US 2026 landscape is defined by the 2025 National Veteran Suicide Prevention Annual Report, released by the Department…
ACA Marketplace in America 2026 The ACA Marketplace in America 2026 is going through one of its most turbulent years since the exchanges first opened their doors back in 2014.…
Alcohol Consumption in America: Where Things Stand in 2026 Few public health topics carry the breadth and urgency of alcohol consumption in the United States. Alcohol is the most widely…
Heart Disease in the UK 2026 Heart and circulatory disease — the umbrella term that encompasses coronary heart disease, heart failure, stroke, atrial fibrillation, vascular dementia, and a range of…
What Do Dementia in UK Tell Us in 2026? Dementia is no longer a looming public health crisis on the United Kingdom's horizon — it has arrived, fully formed, at…
What is the State of Vaccination in the UK in 2026? Vaccination is one of the most cost-effective public health interventions in the history of medicine, and the United Kingdom…
Skin Cancer in Australia 2026 Australia holds the unwanted distinction of being the skin cancer capital of the world. No other country records a higher rate of skin cancer diagnoses,…
GLP-1 Overdose in America 2026 The GLP-1 overdose crisis in America has quietly escalated alongside the explosive popularity of weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. What…